Lido Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Buy |
12,521
+171
| +1% | +$29.4K | 0.01% | 737 |
|
|
2026
Q1 | $2.09M | Sell |
12,350
-20,288
| -62% | -$3.47M | 0.01% | 693 |
|
|
2025
Q4 | $4.74M | Buy |
32,638
+139
| +0.4% | +$22.6K | 0.01% | 481 |
|
|
2025
Q3 | $4.69M | Sell |
32,499
-1,451
| -4% | -$198K | 0.01% | 459 |
|
|
2025
Q2 | $4.3M | Buy |
33,950
+133
| +0.4% | +$16.3K | 0.02% | 413 |
|
|
2025
Q1 | $4.33M | Buy |
33,817
+1,580
| +5% | +$214K | 0.02% | 373 |
|
|
2024
Q4 | $4.26M | Sell |
32,237
-3,786
| -11% | -$532K | 0.02% | 358 |
|
|
2024
Q3 | $5.25M | Sell |
36,023
-4,336
| -11% | -$627K | 0.03% | 301 |
|
|
2024
Q2 | $5.54M | Buy |
40,359
+907
| +2% | +$121K | 0.03% | 272 |
|
|
2024
Q1 | $5.41M | Buy |
39,452
+968
| +3% | +$132K | 0.03% | 269 |
|
|
2023
Q4 | $5.23M | Buy |
38,484
+1,340
| +4% | +$163K | 0.04% | 257 |
|
|
2023
Q3 | $4.54M | Buy |
37,144
+1,769
| +5% | +$225K | 0.03% | 258 |
|
|
2023
Q2 | $4.49M | Buy |
35,375
+2,662
| +8% | +$346K | 0.03% | 240 |
|
|
2023
Q1 | $4.23M | Buy |
32,713
+312
| +1% | +$40.8K | 0.04% | 228 |
|
|
2022
Q4 | $4.25M | Buy |
32,401
+1,073
| +3% | +$139K | 0.05% | 186 |
|
|
2022
Q3 | $3.66M | Buy |
31,328
+1,330
| +4% | +$165K | 0.05% | 181 |
|
|
2022
Q2 | $3.53M | Sell |
29,998
-379
| -1% | -$45K | 0.05% | 161 |
|
|
2022
Q1 | $3.96M | Sell |
30,377
-1,185
| -4% | -$154K | 0.04% | 169 |
|
|
2021
Q4 | $4.82M | Buy |
31,562
+3,935
| +14% | +$609K | 0.05% | 165 |
|
|
2021
Q3 | $4.47M | Buy |
27,627
+4,574
| +20% | +$770K | 0.06% | 168 |
|
|
2021
Q2 | $3.77M | Buy |
23,053
+3,142
| +16% | +$484K | 0.05% | 179 |
|
|
2021
Q1 | $3M | Buy |
19,911
+1,345
| +7% | +$214K | 0.05% | 180 |
|
|
2020
Q4 | $2.81M | Sell |
18,566
-841
| -4% | -$120K | 0.06% | 173 |
|
|
2020
Q3 | $2.63M | Buy |
19,407
+814
| +4% | +$110K | 0.07% | 143 |
|
|
2020
Q2 | $2.54M | Buy |
18,593
+1,673
| +10% | +$213K | 0.08% | 135 |
|
|
2020
Q1 | $1.82M | Sell |
16,920
-1,408
| -8% | -$162K | 0.08% | 142 |
|
|
2019
Q4 | $2.21M | Buy |
18,328
+2,827
| +18% | +$315K | 0.09% | 132 |
|
|
2019
Q3 | $1.54M | Buy |
15,501
+494
| +3% | +$51.7K | 0.08% | 154 |
|
|
2019
Q2 | $1.64M | Buy |
15,007
+142
| +1% | +$15.1K | 0.09% | 131 |
|
|
2019
Q1 | $1.66M | Buy |
14,865
+9,435
| +174% | +$1.03M | 0.11% | 122 |
|
|
2018
Q4 | $523K | Buy |
5,430
+1,174
| +28% | +$125K | 0.05% | 218 |
|
|
2018
Q3 | $519K | Buy |
4,256
+875
| +26% | +$103K | 0.05% | 234 |
|
|
2018
Q2 | $371K | Buy |
3,381
+585
| +21% | +$62.6K | 0.04% | 266 |
|
|
2018
Q1 | $298K | Buy |
2,796
+437
| +19% | +$48.4K | 0.04% | 283 |
|
|
2017
Q4 | $251K | Buy |
2,359
+157
| +7% | +$16.8K | 0.04% | 255 |
|
|
2017
Q3 | $230K | Buy |
+2,202
| New | +$235K | 0.04% | 242 |
|
Other funds holding IBB
CB
Lido Advisors's IBB Position: Q2 2026 in Review
Lido Advisors increased its iShares Biotechnology ETF (IBB) stake by 1.4% in Q2 2026, buying an estimated $29.4K and bringing the position to 12,521 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #737.
Lido Advisors first reported a position in IBB in Q3 2017 and has held it in 36 quarters since. The position peaked at $5.54M in Q2 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Lido Advisors held 12,521 shares of iShares Biotechnology ETF worth $2.38M as of Q2 2026.
- Lido Advisors bought 171 iShares Biotechnology ETF shares in Q2 2026, an estimated $29.4K.
- iShares Biotechnology ETF made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #737 holding.
- Lido Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 36 quarters since.
- Lido Advisors's iShares Biotechnology ETF position peaked at $5.54M in Q2 2024.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.